BD launches closed IV catheter system for protecting healthcare
workers
3 August 2009
BD Medical, a segment of BD (Becton, Dickinson and Company),
has announced the UK launch of the latest BD Nexiva closed intravenous
(IV) catheter system designed to reduce healthcare workers’ risk of needlestick injuries and minimise exposure to blood.
The system includes the BD QSyte Luer access split septum to help
reduce catheter-related bloodstream infections (CRBSIs). It also
introduces a range of new features for ease of use and performance
“BD continues to grow its portfolio of innovative products designed
to help healthcare organisations in the UK and around the world protect
their healthcare workers and patients from infection,” said Suzanne
Grant, Business Director, BD Medical, Medical Surgical Systems.
“The latest BD Nexiva closed IV catheter system reflects our ongoing
efforts to improve clinical efficacy and patient comfort in infusion
therapy it not only simplifies the IV therapy process, but also is
designed to remove some typical sources of risk.”
Studies have shown that needlestick injuries are a significant risk
to the physical and psychological health of nurses, and cause
significant additional costs to healthcare provision [1].
Used for peripheral venous access, the all-in-one BD Nexiva system is
designed to reduce insertion attempts and limit healthcare workers'
exposure to blood with its innovative blood-containment system that
helps minimise blood leakage from the catheter hub. This
safety-engineered system is also designed to reduce needlestick injury
by using passive needle-shielding technology that does not compromise
the insertion techniques.
Studies in Europe have estimated that the associated costs of CRBSIs
may be hundreds of millions of euros. An important feature incorporated
into the BD Nexiva is the BD QSyte Luer access
split septum, which offers a straight and unobstructed fluid path, high
flow rates, clear visibility and cleanability.
A split septum needle access system has 64-70% lower CRBSI rates than
mechanical valves [3]. By eliminating the complexities of mechanical
valves, this split-septum device helps reduce the number of places where
bacteria may thrive [4].
In fact, comparison studies found that patients are three times more
likely, on average, to develop a CRBSI with mechanical valves versus a
split-septum needleless access system [2].
References
1. Royal College of Nursing, Needlestick Injury in 2008.
2. E Tacconelli, G Smith, K Hieke, A Lafuma, P Bastide. Epidemiology,
medical outcomes and costs of catheter-related bloodstream infections in
intensive care units of four European countries: literature and
registry-based estimates. Journal of Hospital Infection, Volume
72, Issue 2, Pages 97-103.
3. Rupp ME, Sholtz LA, Jourdan DR, et al. Outbreak of
bloodstream infection temporally associated with the use of an
intravascular needleless valve. CID. 2007;44:1408-1414.
Salgado CD, Chinnes L, Paczesny TH, Cantey JR. Increased rate of
catheter-related bloodstream infection associated with use of a
needleless mechanical valve device at a long-term acute care hospital.
Infect Control Hosp Epidemiol. 2007;28: 684-688.
4. Karchmer TB, Wood C, Ohl CA, et al. Contamination of
mechanical valve needleless devices may contribute to catheter-related
bloodstream infections. SHEA 2006 Presentation Number: 221
Poster Board Number: 47.
Bookmark this page